BFH772

BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM[1].

Product Specifications

CAS Number

[890128-81-1]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

VEGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/BFH772.html

Concentration

10mM

Purity

96.67

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(NC1=CC(C(F)(F)F)=CC=C1)C2=CC=CC3=CC(OC4=NC=NC(CO)=C4)=CC=C32

Molecular Formula

C23H16F3N3O3

Molecular Weight

439.39

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Bold G, et al. A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. J Med Chem. 2016 Jan 14;59 (1) :132-46.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Isoform

VEGFR2/KDR/Flk-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-08555AF750 100 µL

Mouse Monoclonal Glyoxalase I Antibody (CPTC-GLO1-1) [Alexa Fluor 750]

Ask

View Details

221305-01 50 µL

Casein Kinase IIbeta, phosphorylated (S209) (Casein Kinase II Subunit beta, CK II beta, Phosvitin, Protein G5a, CSNK2B, CK2N, G5A, CKIIb, CK2B) discontinued

Ask

View Details

221305-02 100 µL

Casein Kinase IIbeta, phosphorylated (S209) (Casein Kinase II Subunit beta, CK II beta, Phosvitin, Protein G5a, CSNK2B, CK2N, G5A, CKIIb, CK2B) discontinued

Ask

View Details

350978 96 Tests

CD26, BioAssayTM ELISA Kit (Human) discontinued

Ask

View Details

MBS8217050-01 15 nmol

PPP2R2B siRNA (Human)

Ask

View Details

MBS8217050-02 30 nmol

PPP2R2B siRNA (Human)

Ask

View Details